Small Pharma Reports Fiscal First Quarter 2023 Highlights

FILAMENT HEALTH ANNOUNCES CLOSING OF $2,500,080 PRIVATE PLACEMENT

Numinus Wellness Inc. Reports Q3 2022 Results

Psychedelic Bulletin #111 – Psychedelics on Netflix; House Adopts 2 Psychedelic...

MDMA: Rolling from Counterculture to the Clinic Counter

PT337 – Lauren Katalinich & Anya Oleksiuk – The Psychedelic Society:...

Silo Pharma Announces Positive Results in Subcutaneous Delivery of its Novel...

Optimi Health Finalizes Psilocybin Supply Agreement With Bloom Psychedelic Therapy And...

PharmaTher Announces Notice of Allowance for U.S. Patent Covering Ketamine for...

FILAMENT HEALTH ISSUED THIRD PATENT BY UNITED STATES PATENT AND TRADEMARK...

Load more